The significantly longer half-life of Flyrcado (109 minutes) allows for it to be manufactured at an offsite pharmacy and delivered as a ready-to-use unit dose. The approval was supported by data from ...

The Society of Nuclear Medicine and Molecular Imaging (SNMMI), American Society of Nuclear Cardiology (ASNC), European Association of Nuclear Medicine (EANM), and American College of Nuclear Medicine ...

BARCELONA, Spain ― Artificial intelligence (AI) software substantially reduced false positives on myocardial perfusion imaging (MPI) for the diagnosis of coronary artery disease in high-risk patients, ...

This screening test measures how well blood flows through your heart. It may be used to diagnose coronary artery disease or to assess damage caused by a heart attack. Share on Pinterest JazzIRT/Getty ...

Researchers from the Mayo Clinic have reported findings from the preclinical evaluation of a novel cardiac targeting peptide (CTP)-based radiotracer – [68Ga]NOTA-CTP – being developed as a myocardial ...

Figure 1. Reversible heart damage in a PA patient: Pre- vs. post-adrenalectomy 68 Ga-FAPI-04 PET/CMR in an APA patient, showing decreased uptake in the basal inferoseptal segment. NEW ORLEANS (June 22 ...

NEW YORK, July 17 (Praxis Press) Studies suggest that cardiomyocytes undergo apoptosis after myocardial infarction (MI), and characterization of the extent and timeline of this phenomenon might help ...

The significantly longer half-life of Flyrcado (109 minutes) allows for it to be manufactured at an offisite pharmacy and delivered as a ready-to-use unit dose. The Food and Drug Administration (FDA) ...

A heart perfusion imaging scan, or myocardial perfusion scan, is a test that tells doctors how well a person’s heart pumps blood. Doctors may use this test when diagnosing the cause of chest pain or ...